Concepedia

Shuanglin Han

SH

Statistics

Publications

6

Citations

235

H-Index

6

Active since

2020

Affiliations

Westmead Institute for Medical Research(Current)

Westmead Hospital

The University of Sydney

Westmead Institute

Deakin University

Shuanglin Han is an author at Westmead Institute for Medical Research specializing in life sciences, metabolic liver disease, and liver disease.

Publications per year

2020–2021

6

Publications

6

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

Gang Zhou, Sarah Da Won Bae, Romario Nguyen et al. · Cancer Letters · 2020 · 60 citations · Full text

, , +14

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

Ratna Sari Wijaya, Scott Read, Naomi R. Truong et al. · Gut · 2020 · 55 citations

, , +17

Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model

Kevin L. Zhou, Xiaoqi Huo, Romario Nguyen et al. · Journal of Controlled Release · 2021 · 53 citations · Full text

, , +16

Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus

Ali Bayoumi, Asmaa Elsayed, Shuanglin Han et al. · Advanced Science · 2021 · 27 citations · Full text

, , +17

Expansion of dysfunctional CD56‐CD16+ NK cells in chronic hepatitis B patients

Ratna Sari Wijaya, Scott Read, Stephen D. Schibeci et al. · Liver International · 2021 · 22 citations

, , +14

1–5 of 6